Bayer AG said a US court ruled in favour of the German drugs and chemicals maker in a case in which Indian generic drug maker Dr Reddy's Laboratories challenged the validity of two US patents for antibiotic Avelox. Dr Reddy's had filed an Abbreviated New Drug Application (ANDA) for approval of a generic version of Avelox prior to the expiration of Bayer's patents, the German drugs and chemicals maker said in a statement. 'Under US law, the filing of the ANDA is an act of patent infringement,' Bayer said, adding it is nonetheless not unusual for generic drug companies to file ANDAs on successful pharmaceutical products prior to the expiration of the relevant patents.

Posted by GEN-ERIC at 12:09:37 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/1372

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)